Inhibikase Therapeutics, Inc. (IKT)

NASDAQ: IKT · Real-Time Price · USD

1.995

-0.025 (-1.24%)

At close: Jul 10, 2025, 4:00 PM

2.000

0.00 (0.00%)

Pre-market: Jul 11, 2025, 8:00 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2017 - 2018
Protein Kinase Inhibitor Therapeutics	260.50K	Log In	Log In	Log In	Log In	Upgrade
Protein Kinase Inhibitor Therapeutics Growth	111.03%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2017 - 2018
United States	260.50K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	111.03%	Log In	Log In	Log In	Log In	Upgrade